What type of study is this?

This is a Validation Study study.

What question did this study set out to answer?

This research aims to characterize the immune landscape in Mantle Cell Lymphoma and its implications for prognosis and treatment.

December 8, 2025Blood

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

View Full Paper

Ask AI

Bookmark

Authors

MZMingxia ZhuLiaocheng University HJHongmei JingPeking University

Discussion

Member takes

Implication

Novel immune classifications reveal significant prognostic differences in MCL patients, indicating tailored therapeutic strategies may enhance outcomes.

Key Points

This research aims to characterize the immune landscape in Mantle Cell Lymphoma and its implications for prognosis and treatment.
Gene expression profiles from 403 MCL samples were integrated from 8 GEO datasets.
TIME composition was assessed with xCell and classified using hierarchical clustering.
Differences in immune gene expression and clinical outcomes were analyzed across the datasets.
Three immune subtypes of MCL were identified with distinct prognostic profiles.
IM1 demonstrated the most favorable prognosis and higher immune checkpoint expression.
IM3 showed genomic instability and resistance to ibrutinib, indicating a unique treatment response.

Cite This Study

Zhu et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d464 https://doi.org/10.1182/blood-2025-1821

View Full Paper

Ask AI

Bookmark

Implication

Novel immune classifications reveal significant prognostic differences in MCL patients, indicating tailored therapeutic strategies may enhance outcomes.

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider